COMMETS- Combination MCI Metabolic Syndrome

Conditions: Alzheimer Disease; Mild Cognitive Impairment; Metabolic Syndrome Interventions: Drug: Semaglutide; Drug: Intranasal insulin; Other: Semaglutide placebo; Other: Intranasal insulin placebo Sponsors: Rutgers, The State University of New Jersey; Alzheimer ' s Association Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials